ChangeBridge: Patent Apps - Pharma (A61K)

USPTO Patent Application: Dental Composition with Stable Paste Properties

The USPTO has published a new patent application detailing a dental composition designed for stable paste properties. The invention focuses on a specific filler composition and its surface treatment to improve long-term storage stability for dental materials.

USPTO Patent Application: Method for Coloring Dental Ceramic

The USPTO has published a patent application detailing a method for coloring dental ceramic using a solution containing specific metal ions. The application, filed by inventors from Japan, describes a process involving contacting the dental ceramic with a coloring liquid where the difference between standard oxidation-reduction potentials of at least two metal ions is between 0.5 and 4.0.

USPTO Patent Application: Dental Composition Production Method

The USPTO has published a patent application (US20260083644A1) detailing a method for producing dental polymerizable compositions or intermediates with improved storage stability. The method involves specific steps for disposing and operating a composition within a container to achieve high yield and stability.

USPTO Publishes Antiseptic Wipes Patent Application

The USPTO published a patent application for antiseptic wipes on March 26, 2026. The application details a cleansing composition including an antiseptic, humectant, emollient, surfactant, and monohydric alcohol, designed for use on a cloth. The invention also covers methods of preparing and packaging the wipes.

USPTO Patent Application: Compounds for Treating Parasitic Protozoa Infections

The USPTO has published a new patent application (US20260083728A1) detailing compounds for treating infections caused by parasitic protozoa, specifically Leishmania or Trypanosoma. The application was filed on September 18, 2023, by inventors from Karl WERBOVETZ et al.

USPTO Patent Application: Methods for Increasing Hematopoietic Stem Cells

The USPTO has published a patent application from Imago Biosciences, Inc. detailing methods for increasing hematopoietic stem cells and treating bone marrow failure using an LSD1 inhibitor. The application was filed on December 15, 2023, and published as US20260083729A1.

USPTO Patent Application: Dapiprazole for Eye Disorders

The USPTO has published a patent application (US20260083730A1) for a method of treating eye disorders using dapiprazole. The application, filed by Baradaina LLC, details a liquid composition for treating conditions such as presbyopia, glaucoma, or halos and glare.

Uveal Melanoma Treatment Patent Application

The USPTO has published a patent application (US20260083731A1) detailing methods for treating uveal melanoma using a PKC inhibitor. The application, filed on August 25, 2023, by inventors Matthew Anthony Maurer, Michael Gabriel O'Quigley, and Julie Hambleton, focuses on neoadjuvant and/or adjuvant therapy to reduce metastasis and preserve eye function.

USPTO Patent Application: Upadacitinib Pharmaceutical Composition

The USPTO has published a new patent application (US20260083732A1) detailing a pharmaceutical composition for upadacitinib. The application, filed on September 6, 2023, describes a formulation involving upadacitinib, a hydrophobic release-controlling polymer, a pH modifier, and other excipients.

Collagenase Compositions for Orthodontic Procedures Patent Application

The USPTO has published a patent application detailing compositions comprising collagenase and their uses in orthodontic procedures. The application, filed by inventors from Israel, describes potential uses for recombinant collagenase and modified forms thereof in dental treatments.